HCA Healthcare, Inc. (NYSE:HCA) Holdings Lifted by AE Wealth Management LLC

AE Wealth Management LLC grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 28.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,848 shares of the company’s stock after purchasing an additional 3,485 shares during the period. AE Wealth Management LLC’s holdings in HCA Healthcare were worth $5,092,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the stock. Canada Pension Plan Investment Board grew its holdings in shares of HCA Healthcare by 8.1% during the 2nd quarter. Canada Pension Plan Investment Board now owns 251,277 shares of the company’s stock valued at $80,730,000 after acquiring an additional 18,747 shares in the last quarter. Benjamin F. Edwards & Company Inc. acquired a new position in HCA Healthcare in the 2nd quarter worth about $33,000. Ieq Capital LLC lifted its holdings in shares of HCA Healthcare by 32.8% during the 2nd quarter. Ieq Capital LLC now owns 8,408 shares of the company’s stock valued at $2,701,000 after buying an additional 2,075 shares during the last quarter. Intech Investment Management LLC raised its position in HCA Healthcare by 4.5% during the second quarter. Intech Investment Management LLC now owns 203,163 shares of the company’s stock valued at $65,272,000 after acquiring an additional 8,703 shares in the last quarter. Finally, Leuthold Group LLC increased its stake in shares of HCA Healthcare by 9.0% during the 2nd quarter. Leuthold Group LLC now owns 19,920 shares of the company’s stock worth $6,400,000 after purchasing an additional 1,648 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at HCA Healthcare

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,202 shares of company stock worth $6,407,273. Insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Up 0.3 %

Shares of HCA opened at $404.66 on Friday. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $405.70. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The company has a 50-day moving average price of $370.57 and a two-hundred day moving average price of $340.65. The stock has a market cap of $105.99 billion, a price-to-earnings ratio of 20.17, a P/E/G ratio of 1.46 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. During the same quarter in the previous year, the company earned $4.29 EPS. The firm’s revenue for the quarter was up 10.3% compared to the same quarter last year. Equities analysts predict that HCA Healthcare, Inc. will post 22.46 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a dividend of $0.66 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.65%. HCA Healthcare’s dividend payout ratio is 13.16%.

Analyst Upgrades and Downgrades

HCA has been the topic of several analyst reports. UBS Group increased their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Deutsche Bank Aktiengesellschaft upped their target price on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research report on Friday, June 28th. Robert W. Baird began coverage on shares of HCA Healthcare in a report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price objective for the company. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Finally, Wells Fargo & Company lifted their price objective on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 30th. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.